APA (7th ed.) Citation

E, K., M, H., V, S. M., I, M., N, W., AM, V., . . . M, V. (2021). Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(29), . https://doi.org/10.2807/1560-7917.ES.2021.26.29.2100670

Chicago Style (17th ed.) Citation

E, Kissling, et al. "Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection in Adults Aged 65 Years and Older in Primary Care: I-MOVE-COVID-19 Project, Europe, December 2020 to May 2021." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 26, no. 29 (2021). https://doi.org/10.2807/1560-7917.ES.2021.26.29.2100670.

MLA (9th ed.) Citation

E, Kissling, et al. "Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection in Adults Aged 65 Years and Older in Primary Care: I-MOVE-COVID-19 Project, Europe, December 2020 to May 2021." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 26, no. 29, 2021, https://doi.org/10.2807/1560-7917.ES.2021.26.29.2100670.